 |
BioWorld-International-2004-01-14
Elan's Former Neurex Product, Prialt, Hits Phase III Endpoint
Elan's Former Neurex Product, Prialt, Hits Phase III Endpoint
Elan Corp. plc aims to launch its non-opioid peptide-based analgesic Prialt "no later" than the first quarter of 2005, following news that the compound met its primary endpoint in a trial of 220 patients with severe chronic pain who had not obtained relief with other therapies. (BioWorld International)